Tramadol is sedating for a significant number of people who take it. Somnolence (drowsiness or sleepiness) is one of the most commonly reported side effects, listed by the FDA among adverse reactions occurring in more than 15% of patients. In clinical trials for chronic pain, about 25% of patients reported drowsiness within 90 days of starting the medication.
How Common Drowsiness Is
FDA-approved labeling for tramadol breaks down the timeline clearly. In chronic pain trials involving 427 patients, 16% reported drowsiness within the first week. That number climbed to 23% by 30 days and 25% by 90 days. In an osteoarthritis trial comparing tramadol to placebo, 37% of patients on tramadol reported somnolence versus 22% on placebo.
There’s a silver lining in that data, though. The osteoarthritis study also tracked patients through an earlier open-label phase (before the blinded comparison), and only about 9% reported drowsiness during that period. This suggests that for many people, the sedation becomes less noticeable over time as the body adjusts. The first few weeks tend to be the worst.
Why Tramadol Causes Sleepiness
Tramadol works through two separate pathways, and both can contribute to drowsiness. First, it’s a weak opioid. It binds to the same brain receptors as stronger painkillers like morphine, though with considerably less potency. Your liver converts tramadol into an active metabolite that’s actually about six times stronger than the original drug at activating those receptors. This opioid activity slows down the central nervous system, which is the primary driver of sedation.
Second, tramadol blocks the reabsorption of serotonin and norepinephrine, similar to how some antidepressants work. This dual mechanism is unusual for a painkiller and adds another layer of central nervous system effects that can influence alertness, mood, and sleep patterns.
Tramadol vs. Stronger Opioids
Tramadol is considerably weaker than traditional opioids. In a head-to-head surgical study comparing tramadol to oxycodone, the potency ratio was roughly 8 to 1, meaning patients needed about eight times more tramadol to get the same pain relief as oxycodone. Clinical trials have found that tramadol produces reduced levels of certain opioid-related side effects, including sedation and respiratory depression, compared to stronger painkillers. That said, it still carries real sedative potential and is not side-effect-free. Rates of dizziness, nausea, and headache were similar to those seen with stronger opioids in some comparisons.
Your Genetics Play a Role
How sedating tramadol feels to you depends partly on your genes. A liver enzyme called CYP2D6 is responsible for converting tramadol into its more potent active form. People fall into different categories based on how efficiently this enzyme works, and the differences are dramatic.
About 7% of the population are “poor metabolizers” who convert very little tramadol into its active form. These people tend to get less pain relief but also less sedation. On the other end, “ultrarapid metabolizers” convert tramadol much faster and more completely, flooding the body with its stronger metabolite. For these individuals, even standard doses can produce extreme sleepiness, confusion, shallow breathing, and in rare cases life-threatening respiratory depression. The FDA warns that ultrarapid metabolizers should not use tramadol at all.
Most people fall somewhere in the middle, but there’s no simple way to know your metabolizer status without genetic testing. If tramadol hits you unusually hard or barely seems to work, your CYP2D6 activity is likely part of the explanation.
What Makes Sedation Worse
The biggest risk factor for severe tramadol sedation is combining it with other substances that depress the central nervous system. The FDA places a boxed warning (its most serious alert) on tramadol’s label about this. Mixing tramadol with benzodiazepines, sleep medications, anti-anxiety drugs, muscle relaxants, other opioids, or alcohol can cause profound sedation, dangerously slowed breathing, coma, and death. Observational studies have confirmed that combining opioids with benzodiazepines increases the risk of drug-related death compared to taking opioids alone.
Antipsychotics, antihistamines, and general anesthetics also amplify tramadol’s sedative effects. If you take any medication that causes drowsiness on its own, expect the combination with tramadol to be significantly more sedating than either drug alone.
Older Adults Face Higher Risk
People over 75 have a prolonged elimination half-life for tramadol, meaning the drug stays active in their system longer. Starting doses are typically lower for this group (25 mg per day) with a lower maximum ceiling of 300 mg daily, compared to 400 mg for younger adults. The lingering sedation, combined with dizziness and fatigue, raises the risk of falls and fractures in older adults, which is one of the most consistently identified safety concerns with opioid use in this population.
Driving and Daily Activities
The FDA cautions that tramadol may impair the mental and physical abilities needed for hazardous tasks like driving. This is especially true during the first few days of treatment, after a dose increase, or when tramadol is combined with anything else that causes drowsiness. Drowsiness can persist for several hours after a dose and may carry over into the next day, particularly with extended-release formulations.
The practical approach is to take your first dose at a time when you won’t need to drive or operate heavy equipment, so you can gauge how it affects you personally before putting yourself in a situation that demands full alertness.
Reducing Drowsiness Over Time
Tramadol prescribing typically starts with a low dose and increases gradually. Immediate-release tablets often begin at just 25 mg per day, taken in the morning, with slow increases as tolerated. Extended-release versions start at 100 mg once daily. This gradual approach gives the body time to develop some tolerance to the sedative effects before the dose reaches therapeutic levels.
For many people, drowsiness fades as the body adjusts over several weeks. Avoiding alcohol and other sedating substances makes a meaningful difference. Timing your dose so that peak drowsiness coincides with bedtime (rather than your morning commute) is another practical strategy, though this depends on your dosing schedule and pain management needs. If sedation remains a problem beyond the initial adjustment period, that’s worth discussing with your prescriber, as the dose or timing may need adjustment.